Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02112695
Other study ID # 1208051
Secondary ID 2013-004733-32
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2014
Est. completion date July 7, 2017

Study information

Verified date October 2017
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Abnormal opioid system have been identified in addictive behavior and activity of the opioid system has also shown a strong link with the nutritional balance. A significant increase in endorphin levels was noticed after exercise, proportional to the duration and intensity of this activity. One brain imaging study showed an increase in opioid activity in athletes after endurance training. However , a decrease in opioid tone related to receptor desensitization in the brain has been raised in the sport and it is possible to feel like , the subject must perform physical exercise more frequently . Consequently, in order to deepen the hypothesis of addiction in high-level sport , the brain opioid activity should be assessed pre- training compared to a group of sedentary control subjects .

Preliminary results of a previous study the investigators are conducting on anorexia nervosa (AN ) show abnormalities that appear to be involved in self addiction anorexia nervosa and the regulation of gonadal function. However, the relation of cause and effect between these anomalies and undernutrition remains to be determined . Given the addictive component in the endurance sport and the variability of the nutritional status of its practitioners , evaluation of brain activity in these subjects could provide additional answers.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date July 7, 2017
Est. primary completion date July 6, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

For High-level sportswomen :

- 18-35-year-old

- High-level sportswomen

- BMI>19kg/m2

- Absence of eating disorders

- In pre-competition period

- Signature of written consent

For controls :

- 18-35-year-old

- Sedentary normal weight women

- BMI>19kg/m2

- Normal nutritional markers

- Absence of eating disorders or other psychiatric or organic diseases

Exclusion Criteria:

- Oral contraception

- Heart failure

- Neuroleptics, antiparkinson drugs, alpha-methyl-dopa, beta blockers, inhibitors of monoamine oxidase-A or MOA-B, tricyclic antidepressants, selective serotonin reuptake inhibitor, thyme-regulators (lithium), anticonvulsant drugs, codeine, morphine, drugs containing tramadol, dopaminergic drugs

Study Design


Related Conditions & MeSH terms


Intervention

Other:
[11C]diprenorphine
3 micrograms [11C]diprenorphine - intravenous use - 1 time

Locations

Country Name City State
France Service d'Endocrinologie - CHU Saint-Etienne Saint-Etienne

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Ministry of Health, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary [11C]diprenorphine binding potential Value of [11C]diprenorphin binding potential in predifined brains regions. [11C]diprenorphin BP will be evaluated by brain positron emission tomography and MRI exam 2 weeks
Secondary correlation [11C]diprenorphine BP Correlation between [11C]Diprenorphine binding potential and plasma endogenous opioid levels 2 weeks
Secondary correlation [11C]diprenorphine BP Correlation between [11C]Diprenorphine binding potential and psychometric score evaluating addictive behavior, reward and positive reinforcement 2 weeks
Secondary correlation [11C]diprenorphine BP Correlation between [11C]Diprenorphine binding potential and appetite regulating hormones 2 weeks
Secondary correlation [11C]diprenorphine BP Correlation between [11C]Diprenorphine binding potential and LH response during GnRH test 2 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05489666 - Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females N/A
Completed NCT02519751 - New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass N/A
Completed NCT04642144 - Effect of Infusion of Yerba Mate on Oxidative Stress, Physiology, and Performance of Trained Cyclists N/A
Completed NCT02458599 - Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise N/A
Completed NCT03083509 - A Physiological Profile of Recovery From Resistance, Endurance, and Mixed Exercise Types N/A